share_log

HC Wainwright & Co. Maintains Buy on Revolution Medicines, Raises Price Target to $72

Benzinga ·  07:04  · Ratings

HC Wainwright & Co. analyst Robert Burns maintains Revolution Medicines (NASDAQ:RVMD) with a Buy and raises the price target from $64 to $72.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment